Clinical Trial Update: Urinary CA19-9 Level in the Differential Diagnosis of Neurogenic and Non-Neurogenic Lower Urinary Tract Dysfunction in Children [NA]

View source ↗

Summary

A clinical trial update evaluating urinary CA19-9 levels to differentiate neurogenic from non-neurogenic lower urinary tract dysfunction in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Dysfunction
• Neurogenic Bladder
• Non-neurogenic Lower Urinary Tract Dysfunction

Snippet

Sponsor: Marmara University | Conditions: Lower Urinary Track Symptoms | NA | Status: UNKNOWN